Peipei Lin
Overview
Explore the profile of Peipei Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sun H, Ren Y, Zhou X, Chen Q, Liu Y, Zhu C, et al.
Technol Cancer Res Treat
. 2023 Oct;
22:15330338231207765.
PMID: 37872685
Dual specificity phosphatase 1 (DUSP1) is high-expressed in various cancers and plays an important role in the cellular response to agents that damage DNA. We aimed to investigate the expressions...
2.
Jacome Burbano M, Robin J, Bauwens S, Martin M, Donati E, Martinez L, et al.
Commun Biol
. 2023 May;
6(1):561.
PMID: 37231173
Telomeric repeat binding factor 2 (TRF2) binds to telomeres and protects chromosome ends against the DNA damage response and senescence. Although the expression of TRF2 is downregulated upon cellular senescence...
3.
Wang L, Zhang Q, Ye L, Ye X, Yang W, Zhang H, et al.
Br J Cancer
. 2022 Dec;
128(4):691-701.
PMID: 36482192
Background: Decitabine (DAC) is used as the first-line therapy in patients with higher-risk myelodysplastic syndromes (HR-MDS) and elderly acute myeloid leukaemia (AML) patients unsuitable for intensive chemotherapy. However, the clinical...
4.
Ruan H, Sun H, Guo Y, Ding Y, Liu Y, Ying S, et al.
Gen Thorac Cardiovasc Surg
. 2022 Jun;
70(12):1022-1031.
PMID: 35716296
Objective: This research is aimed to develop the prognostic nomogram and novel risk-scoring system for small cell lung cancer (SCLC) with different patterns of metastases. Methods: Data on SCLC patients...
5.
Sun H, Chen Q, Liu W, Liu Y, Ruan S, Zhu C, et al.
J Cancer
. 2021 Oct;
12(22):6883-6893.
PMID: 34659576
Tumor-associated calcium signal transducer 2 (TROP2) is over expressed in various kinds of human cancers and plays important roles in the proliferation, invasion and metastasis of tumor cells. However, the...
6.
Yan X, Wang L, Jiang L, Luo Y, Lin P, Yang W, et al.
Cancer Med
. 2021 Feb;
10(5):1759-1771.
PMID: 33609081
Purpose: To explore the relevance of cytogenetic or molecular genetic abnormalities to clinical variables, including clinical and laboratory characteristics and prognosis in Chinese patients with myelodysplastic syndromes (MDS). Methods: A...
7.
Ma L, Jiang L, Yang W, Luo Y, Mei C, Zhou X, et al.
Cancer Med
. 2021 Feb;
10(5):1715-1725.
PMID: 33559357
Chronic myelomonocytic leukemia (CMML) is a rare disease of elderly people characterized by the presence of sustained peripheral blood monocytosis, overlapping features of myeloproliferation, and myelodysplasia. We present a large...
8.
Wang H, Meng H, Wang J, Lou Y, Zhou Y, Lin P, et al.
Front Med
. 2019 Dec;
14(3):327-334.
PMID: 31784918
This study aimed to investigate the prevalence, clinical characteristics, and prognostic impact of 1p32.3 deletion in patients with newly diagnosed multiple myeloma (MM). A retrospective analysis was conducted on 411...
9.
Ren Y, Jiang H, Shi F, Ye L, Luo Y, Zhou X, et al.
Leuk Lymphoma
. 2019 Jan;
60(7):1731-1739.
PMID: 30616472
We retrospectively studied 133 myelodysplastic syndrome patients receiving decitabine during January 2009 and September 2017. The dose of 15 mg/m/d ( = 83) and 20 mg/m/d ( = 50) had...
10.
Ren Y, Mei C, Ye L, Luo Y, Zhou X, Yang H, et al.
Blood Cells Mol Dis
. 2018 Dec;
75:13-19.
PMID: 30530101
We retrospectively analyzed 101 primary MDS patients with complex karyotype during January 2010 and April 2017.The median overall survival (OS) time was 13 (95% CI 9.98-16.02) months, and there was...